Enveric Biosciences, Inc. (ENVB)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.2143 |
| Open | 0.2021 |
| Bid | 0.2130 x 800 |
| Ask | 0.2250 x 900 |
| Day's Range | 0.2021 - 0.2200 |
| 52 Week Range | 0.1700 - 3.7400 |
| Volume | |
| Avg. Volume | 1,953,627 |
| Market Cap | 11.201M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.6670 |
| Earnings Date | Aug 11, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Apr 23, 2008 |
| 1y Target Est | 0.65 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ENVB
Related Research
- Enveric Biosciences, Inc.Daily – Vickers Top Buyers & Sellers for 07/01/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat3 days agoArgus Research
- PR Newswire
Enveric Biosciences to Participate in Upcoming Conferences in June 2022
Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric, will participate in three upcoming conferences:
- PR Newswire
Enveric Biosciences to Participate in the Microdose Psychedelic Capital Conference on May 26, 2022
Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Avani Kanubaddi, President and Chief Operating Officer of Enveric, will participate virtually in Microdose's Psychedelic Capital: May 2022 Conference to be held virtually on May 26, 2022.
- PR Newswire
Enveric Biosciences to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022
Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric, will participate virtually in the H.C. Wainwright Global Investment Conference to be held on May 23-26, 2022.
